Sentinel Initiative: Structure, Function, and Scope; Public Workshop; Request for Comments, 74176-74177 [E8-28797]
Download as PDF
<![CDATA[
74176
Federal Register / Vol. 73, No. 235 / Friday, December 5, 2008 / Notices
child welfare data elements included in
the RPG performance measures can be
found in a State’s automated case
management system, which is often a
Federally funded Statewide Automated
Child Welfare Information System
(SACWIS). If the State elects to
implement a SACWIS, the system is
expected to be a comprehensive
automated case management tool that
meets the needs of all staff involved in
foster care and adoption case
management. A SACWIS is required to
support reporting of data to AFCARS
semi-annually, and annually to
NCANDS. AFCARS reports information
on all children in foster care, while
NCANDS reports information on State
child maltreatment reports. TEDS
admission and discharge data are
collected by State substance abuse
agencies according to their own
information systems for monitoring
substance abuse treatment admissions
and transmitted monthly or quarterly to
the SAMHSA contractor.
As a result of prior Federal
government reporting requirements,
States are already collecting several data
elements needed by the RPGs. The RPGs
can download information from these
existing systems to obtain data to
monitor their program outcomes,
thereby reducing the amount of primary
data collection needed.
Beginning in year two, grantees will
submit a data file with their required
indicator data, according to their final
set of indicators, every six months.
Respondents: RPG Grantees.
ANNUAL BURDEN ESTIMATES
Number of
respondents
Instrument
State, local, or Tribal Government ..................................................................
Private Sector ..................................................................................................
Estimated Total Annual Burden
Hours: 18,603.
Additional Information: Copies of the
proposed collection may be obtained by
writing to the Administration for
Children and Families, Office of
Administration, Office of Information
Services, 370 L’Enfant Promenade, SW.,
Washington, DC 20447, Attn: ACF
Reports Clearance Officer. All requests
should be identified by the title of the
information collection. E-mail address:
infocollection@acf.hhs.gov.
OMB Comment: OMB is required to
make a decision concerning the
collection of information between 30
and 60 days after publication of this
document in the Federal Register.
Therefore, a comment is best assured of
having its full effect if OMB receives it
within 30 days of publication. Written
comments and recommendations for the
proposed information collection should
be sent directly to the following: Office
of Management and Budget, Paperwork
Reduction Project, Fax: 202–395–6974,
Attn: Desk Officer for the
Administration for Children and
Families.
Dated: December 1, 2008.
Janean Chambers,
Reports Clearance Officer.
[FR Doc. E8–28736 Filed 12–4–08; 8:45 am]
dwashington3 on PROD1PC60 with NOTICES
BILLING CODE 4184–01–P
VerDate Aug<31>2005
15:27 Dec 04, 2008
Jkt 217001
31
22
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2008–N–0612]
Sentinel Initiative: Structure, Function,
and Scope; Public Workshop; Request
for Comments
AGENCY: Food and Drug Administration,
HHS.
ACTION: Notice of public workshop;
request for comments.
The Food and Drug Administration
(FDA) is announcing a public workshop
entitled Sentinel Initiative: Structure,
Function, and Scope. The workshop is
co-sponsored by the Food and Drug
Administration and the eHealth
Initiative Foundation, and convened by
the Engelberg Center for Health Care
Reform at the Brookings Institution. The
workshop is intended to bring together
academia; government; patient,
consumer, and provider groups; health
care data owners; industry; and other
interested organizations for an update
on the current status of the Sentinel
Initiative and to allow for comment
from all interested stakeholders.
Specific topics for discussion include
potential governance models and their
implications, and approaches for
ensuring continued involvement of all
stakeholders as the Initiative evolves.
Date and Time: The public workshop
will be held on December 16, 2008, from
9 a.m. to 3:30 p.m.
Location: The public workshop will
be held at the Omni Shoreham Hotel,
2500 Calvert Street NW., Washington,
DC 20008.
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
2
2
Average
burden hours
per response
175.50
175.50
Total burden
hours
10,881
7,722
Contact Person: Melissa Robb, Office
of Critical Path Programs (HF–18), Food
and Drug Administration, 5600 Fishers
Lane, Rockville MD 20857, 301–827–
1516, or e-mail:
Melissa.Robb@fda.hhs.gov.
Registration: To register, please visit:
https://guest.cvent.com/ and insert
‘‘7SN5MQKXSVQ’’ for the event code.
For questions regarding registration, email: engelbergevents@brookings.edu.
If you need special accommodations
due to a disability, please contact Keviar
Warner, 202–624–3271, or e-mail:
Keviar.Warner@ehealthinitiative.org at
least 7 days in advance.
Comments: FDA is holding this public
workshop to provide an update on the
current status of the Sentinel Initiative.
The deadline for submitting comments
regarding this topic is January 16, 2009.
Regardless of attendance at the public
workshop, interested persons may
submit written or electronic comments
to the Division of Dockets Management
(HFA–305), Food and Drug
Administration, 5630Fishers Lane, rm.
1061, Rockville, MD 20852. Submit
electronic comments to https://
www.regulations.gov. Submit a single
copy of electronic comments or two
paper copies of any mailed comments,
except that individuals may submit one
paper copy. Comments are to be
identified with the docket number
found in brackets in the heading of this
document. Received comments may be
seen in the Division of Dockets
Management between 9 a.m. and 4 p.m.,
Monday through Friday.
Please note that on January 15, 2008,
the FDA Division of Dockets
Management Web site transitioned to
the Federal Dockets Management
E:\FR\FM\05DEN1.SGM
05DEN1
Federal Register / Vol. 73, No. 235 / Friday, December 5, 2008 / Notices
System (FDMS). FDMS is a
Government-wide, electronic docket
management system. Electronic
comments or submissions will be
accepted by FDA only through FDMS at
https://www.regulations.gov.
Transcripts: Please be advised that as
soon as a transcript is available, it will
be accessible at https://www.fda.gov/oc/
initiatives/advance/sentinel/. It may be
viewed at the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, rm.
1061, Rockville, MD. A transcript will
also be available in either hardcopy or
on CD–ROM, after submission of a
Freedom of Information request. Written
requests are to be sent to Division of
Freedom of Information (HFI–35), Office
of Management Programs, Food and
Drug Administration, 5600 Fishers
Lane, rm. 6–30, Rockville, MD 20857.
Dated: December 1, 2008.
Jeffrey Shuren,
Associate Commissioner for Policy and
Planning.
[FR Doc. E8–28797 Filed 12–4–08; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
dwashington3 on PROD1PC60 with NOTICES
Agency Information Collection
Activities: Proposed Collection;
Comment Request
In compliance with Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 concerning
opportunity for public comment on
proposed collections of information, the
Substance Abuse and Mental Health
Services Administration (SAMHSA)
will publish periodic summaries of
proposed projects. To request more
information on the proposed projects or
to obtain a copy of the information
collection plans, call the SAMHSA
Reports Clearance Officer on (240) 276–
1243.
Comments are invited on: (a) Whether
the proposed collections of information
are necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
VerDate Aug<31>2005
15:27 Dec 04, 2008
Jkt 217001
of automated collection techniques or
other forms of information technology.
Proposed Project: Evaluation of
SAMHSA’s Minority Fellowship
Program (MFP)—NEW
The Substance Abuse and Mental
Health Services Administration’s Center
for Mental Health Services (CMHS) will
conduct an independent evaluation of
the Minority Fellowship Program
(MFP).
In 1973, in response to a substantial
lack of ethnic and racial minorities in
the mental health professions, the
Center for Minority Health at the
National Institute of Mental Health
established the Minority Fellowship
Program (MFP). Since its move to
SAMHSA in 1992, the MFP has
continued to facilitate the entry of
minority graduate students and
psychiatric residents into mental health
careers and has increased the number of
psychology, psychiatry, nursing, and
social work professionals trained to
provide mental health and substance
abuse services to minority groups. Up
until FY 2007, grantees have been
limited to the American Nurses
Association (ANA), the American
Psychiatric Association (ApA), the
American Psychological Association
(APA), and the Council on Social Work
Education (CSWE). The MFP is
supported by funds from all three
SAMHSA centers, the Center for Mental
Health Services (CMHS), the Center for
Substance Abuse Treatment (CSAT),
and the Center for Substance Abuse
Prevention (CSAP).
With input from SAMHSA staff, the
four pre-2007 grantee organizations, and
two advisory panels (of independent
experts in the MFP and/or culturally
competent behavioral health care, as
well as consumer and family
representatives), a logic model was
designed and a set of data collection
instruments have been developed for
this evaluation. SAMHSA will employ
information that is routinely collected
under existing program requirements
and also will be collecting additional
data that also are necessary for the
conduct of the evaluation. At the end of
each grant year, the grantee
organizations (the ANA, ApA, APA, and
CSWE) will document their activities,
accomplishments, and expenditures and
assessment measures for the most
recently completed fiscal year. In
addition, each grantee will maintain a
database with information on current
and former Fellows. None of the data
collection activities proposed for this
evaluation will be redundant with these
existing reporting requirements and data
sources. The evaluation plan includes
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
74177
gathering information about the MFP
from persons with different experiences
and perspectives on the MFP.
Accordingly, SAMHSA proposes to
conduct the following new data
collection activities:
On-line (Internet-based) surveys:
1. Current SAMHSA MFP Fellows in
each of the four academic disciplines;
2. MFP Alumni who were in the four
programs during the time the program
was administered by SAMHSA; and
3. Current and former members of
Selection and Advisory Committees in
each of the four grantee programs.
Telephone Interviews:
1. Current and former SAMHSA MFP
Staff and other SAMHSA officials
involved in the MFP;
2. Current and former MFP Program
Directors or Senior Staff in each of the
four grantee programs; and
3. Staff in each of the grantee’s host
organizations (i.e. staff in the ANA,
APA, ApA, and CSWE).
The surveys and interview protocols
have been developed to include
questions relevant to each of the
respective stakeholder groups named
above, with similar core questions asked
across all groups.
The resulting data will identify (1)
The historical context in which the MFP
has operated; (2) the processes and
activities established by SAMHSA and
by the grantees to implement the MFP;
(3) the perceptions about how well the
SAMHSA MFP is performing; and (4)
the ability of the program to achieve
particular goals under its purview.
Each new cohort of Fellows will
develop and support the following
goals:
1. Training/mentoring ethnic/racial
minority students and professionals in
mental health/substance abuse
treatment;
2. Increasing the number of ethnic/
racial minority professionals in mental
health/substance abuse treatment;
3. Increasing diversity in mental
health/substance abuse leadership;
4. Increasing professional
contributions in mental health/
substance abuse treatment for minority
populations;
5. Increasing institutional
involvement of ethnic/racial minority
professionals in the areas of mental
health and substance abuse treatment;
and
6. Increasing mental health and
substance abuse services to minority
communities.
The burden estimate for conducting
the surveys and interviews under the
evaluation plan for the MFP is as
follows:
E:\FR\FM\05DEN1.SGM
05DEN1
]]>Agencies
[Federal Register Volume 73, Number 235 (Friday, December 5, 2008)]
[Notices]
[Pages 74176-74177]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-28797]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2008-N-0612]
Sentinel Initiative: Structure, Function, and Scope; Public
Workshop; Request for Comments
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice of public workshop; request for comments.
-----------------------------------------------------------------------
The Food and Drug Administration (FDA) is announcing a public
workshop entitled Sentinel Initiative: Structure, Function, and Scope.
The workshop is co-sponsored by the Food and Drug Administration and
the eHealth Initiative Foundation, and convened by the Engelberg Center
for Health Care Reform at the Brookings Institution. The workshop is
intended to bring together academia; government; patient, consumer, and
provider groups; health care data owners; industry; and other
interested organizations for an update on the current status of the
Sentinel Initiative and to allow for comment from all interested
stakeholders. Specific topics for discussion include potential
governance models and their implications, and approaches for ensuring
continued involvement of all stakeholders as the Initiative evolves.
Date and Time: The public workshop will be held on December 16,
2008, from 9 a.m. to 3:30 p.m.
Location: The public workshop will be held at the Omni Shoreham
Hotel, 2500 Calvert Street NW., Washington, DC 20008.
Contact Person: Melissa Robb, Office of Critical Path Programs (HF-
18), Food and Drug Administration, 5600 Fishers Lane, Rockville MD
20857, 301-827-1516, or e-mail: Melissa.Robb@fda.hhs.gov.
Registration: To register, please visit: https://guest.cvent.com/ and insert ``7SN5MQKXSVQ'' for the event code. For questions regarding
registration, e-mail: engelbergevents@brookings.edu.
If you need special accommodations due to a disability, please
contact Keviar Warner, 202-624-3271, or e-mail:
Keviar.Warner@ehealthinitiative.org at least 7 days in advance.
Comments: FDA is holding this public workshop to provide an update
on the current status of the Sentinel Initiative. The deadline for
submitting comments regarding this topic is January 16, 2009.
Regardless of attendance at the public workshop, interested persons
may submit written or electronic comments to the Division of Dockets
Management (HFA-305), Food and Drug Administration, 5630Fishers Lane,
rm. 1061, Rockville, MD 20852. Submit electronic comments to https://
www.regulations.gov. Submit a single copy of electronic comments or two
paper copies of any mailed comments, except that individuals may submit
one paper copy. Comments are to be identified with the docket number
found in brackets in the heading of this document. Received comments
may be seen in the Division of Dockets Management between 9 a.m. and 4
p.m., Monday through Friday.
Please note that on January 15, 2008, the FDA Division of Dockets
Management Web site transitioned to the Federal Dockets Management
[[Page 74177]]
System (FDMS). FDMS is a Government-wide, electronic docket management
system. Electronic comments or submissions will be accepted by FDA only
through FDMS at https://www.regulations.gov.
Transcripts: Please be advised that as soon as a transcript is
available, it will be accessible at https://www.fda.gov/oc/initiatives/
advance/sentinel/. It may be viewed at the Division of Dockets
Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane,
rm. 1061, Rockville, MD. A transcript will also be available in either
hardcopy or on CD-ROM, after submission of a Freedom of Information
request. Written requests are to be sent to Division of Freedom of
Information (HFI-35), Office of Management Programs, Food and Drug
Administration, 5600 Fishers Lane, rm. 6-30, Rockville, MD 20857.
Dated: December 1, 2008.
Jeffrey Shuren,
Associate Commissioner for Policy and Planning.
[FR Doc. E8-28797 Filed 12-4-08; 8:45 am]
BILLING CODE 4160-01-S
